$2.15 Billion is the total value of Cormorant Asset Management, LP's 73 reported holdings in Q1 2020. The portfolio turnover from Q4 2019 to Q1 2020 was 17.9% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| SPY | New | SPDR S&P 500 ETF TRput | $257,750,000 | – | 1,000,000 | +100.0% | 11.98% | – |
| TPTX | Sell | TURNING POINT THERAPEUTICS I | $136,517,000 | -35.5% | 3,056,797 | -10.0% | 6.34% | -24.9% |
| PRNB | Buy | PRINCIPIA BIOPHARMA INC | $124,698,000 | +14.3% | 2,100,000 | +5.5% | 5.79% | +33.1% |
| BBIO | Buy | BRIDGEBIO PHARMA INC | $85,550,000 | -2.9% | 2,950,000 | +17.4% | 3.98% | +13.1% |
| CCXI | Sell | CHEMOCENTRYX INC | $81,365,000 | -29.1% | 2,025,000 | -30.2% | 3.78% | -17.4% |
| XLRN | New | ACCELERON PHARMA INC | $74,143,000 | – | 825,000 | +100.0% | 3.44% | – |
| RETA | Sell | REATA PHARMACEUTICALS INCcl a | $70,323,000 | -57.9% | 487,206 | -40.3% | 3.27% | -50.9% |
| VIE | Buy | VIELA BIO INC | $66,975,000 | +64.7% | 1,762,500 | +17.7% | 3.11% | +91.9% |
| MRTX | Sell | MIRATI THERAPEUTICS INC | $65,340,000 | -60.5% | 850,000 | -33.7% | 3.04% | -54.0% |
| CNST | Sell | CONSTELLATION PHARMACEUTICALS I | $64,118,000 | -40.8% | 2,040,021 | -11.3% | 2.98% | -31.1% |
| APLS | Sell | APELLIS PHARMACEUTICALS INC | $60,709,000 | -26.6% | 2,266,108 | -16.1% | 2.82% | -14.5% |
| RVMD | New | REVOLUTION MEDICINES INC | $60,627,000 | – | 2,767,078 | +100.0% | 2.82% | – |
| EIDX | Buy | EIDOS THERAPEUTICS INC | $53,889,000 | +89.4% | 1,100,000 | +121.9% | 2.50% | +120.6% |
| YMAB | Buy | Y-MABS THERAPEUTICS INC | $45,210,000 | -9.7% | 1,732,200 | +8.1% | 2.10% | +5.2% |
| ASND | Buy | ASCENDIS PHARMA A Scall | $39,414,000 | +13.3% | 350,000 | +40.0% | 1.83% | +31.9% |
| STOK | Sell | STOKE THERAPEUTICS INC | $39,154,000 | -22.7% | 1,709,765 | -4.4% | 1.82% | -10.0% |
| MRTX | MIRATI THERAPEUTICS INCcall | $38,435,000 | -40.3% | 500,000 | 0.0% | 1.79% | -30.5% | |
| RETA | REATA PHARMACEUTICALS INCcall | $36,085,000 | -29.4% | 250,000 | 0.0% | 1.68% | -17.8% | |
| OMER | Buy | OMEROS CORP | $33,742,000 | +57.0% | 2,523,700 | +65.5% | 1.57% | +83.0% |
| MYOK | MYOKARDIA INC | $32,816,000 | -35.7% | 700,000 | 0.0% | 1.52% | -25.1% | |
| AGEN | New | AGENUS INC | $29,827,000 | – | 12,174,486 | +100.0% | 1.39% | – |
| BHVN | Sell | BIOHAVEN PHARMACTL HLDG CO L | $29,795,000 | -45.3% | 875,551 | -12.4% | 1.38% | -36.3% |
| AXSM | Sell | AXSOME THERAPEUTICS INC | $29,415,000 | -52.6% | 500,000 | -16.7% | 1.37% | -44.8% |
| ASND | Sell | ASCENDIS PHARMA A Ssponsored adr | $28,153,000 | -49.4% | 250,000 | -37.5% | 1.31% | -41.1% |
| NXTC | Sell | NEXTCURE INC | $27,558,000 | -51.1% | 743,400 | -25.7% | 1.28% | -43.1% |
| CRSP | Sell | CRISPR THERAPEUTICS AGnamen akt | $26,735,000 | -56.1% | 630,400 | -37.0% | 1.24% | -48.9% |
| BPMC | Buy | BLUEPRINT MEDICINES CORP | $26,316,000 | -4.8% | 450,000 | +30.4% | 1.22% | +10.9% |
| CCXI | Buy | CHEMOCENTRYX INCcall | $25,113,000 | +154.0% | 625,000 | +150.0% | 1.17% | +195.4% |
| ZYME | ZYMEWORKS INC | $24,829,000 | -22.0% | 700,000 | 0.0% | 1.15% | -9.1% | |
| IGMS | Buy | IGM BIOSCIENCES INC | $23,926,000 | +300.9% | 426,104 | +172.4% | 1.11% | +367.2% |
| RCKT | Sell | ROCKET PHARMACEUTICALS INC | $21,881,000 | -47.7% | 1,568,550 | -14.6% | 1.02% | -39.1% |
| TWST | TWIST BIOSCIENCE CORP | $21,013,000 | +45.6% | 687,149 | 0.0% | 0.98% | +69.4% | |
| AXNX | Sell | AXONICS MODULATION TECHNOLOG | $20,328,000 | -40.0% | 800,000 | -34.6% | 0.94% | -30.1% |
| GLPG | Sell | GALAPAGOS NVspon adr | $19,681,000 | -5.9% | 98,603 | -1.4% | 0.91% | +9.5% |
| MYOV | Buy | MYOVANT SCIENCES LTD | $19,630,000 | -36.8% | 2,600,000 | +30.0% | 0.91% | -26.4% |
| IMVTU | Sell | IMMUNOVANT INCunit 12/18/2024 | $19,396,000 | -26.9% | 1,078,380 | -0.2% | 0.90% | -14.9% |
| TCDA | Sell | TRICIDA INC | $19,315,000 | -44.8% | 877,975 | -5.4% | 0.90% | -35.8% |
| STSA | Sell | SATSUMA PHARMACEUTICALS INC | $17,396,000 | +3.0% | 808,382 | -5.8% | 0.81% | +19.9% |
| ANAB | Buy | ANAPTYSBIO INC | $15,655,000 | +164.0% | 1,107,900 | +203.5% | 0.73% | +206.8% |
| CABA | Sell | CABALETTA BIO INC | $15,373,000 | -48.1% | 2,105,846 | -0.6% | 0.71% | -39.5% |
| ZLAB | Buy | ZAI LAB LTDadr | $14,882,000 | +29.1% | 289,092 | +4.3% | 0.69% | +50.2% |
| SRPT | Sell | SAREPTA THERAPEUTICS INC | $14,673,000 | -54.5% | 150,000 | -40.0% | 0.68% | -47.0% |
| DCPH | Sell | DECIPHERA PHARMACEUTICALS IN | $14,410,000 | -48.6% | 350,000 | -22.2% | 0.67% | -40.1% |
| BEAM | New | BEAM THERAPEUTICS INC | $14,336,000 | – | 796,429 | +100.0% | 0.67% | – |
| AKRO | Sell | AKERO THERAPEUTICS INC | $13,622,000 | -17.1% | 642,539 | -13.2% | 0.63% | -3.5% |
| QTNT | Sell | QUOTIENT LTD | $12,488,000 | -62.5% | 3,161,500 | -9.7% | 0.58% | -56.3% |
| QURE | Sell | UNIQURE NV | $11,863,000 | -58.6% | 250,000 | -37.5% | 0.55% | -51.8% |
| ARGX | Sell | ARGENX SEsponsored adr | $10,538,000 | -34.4% | 80,000 | -20.0% | 0.49% | -23.6% |
| FIXX | New | HOMOLOGY MEDICINES INC | $9,324,000 | – | 600,000 | +100.0% | 0.43% | – |
| SRNE | Buy | SORRENTO THERAPEUTICS INC | $9,200,000 | -32.0% | 5,000,000 | +25.0% | 0.43% | -20.9% |
| INSP | Sell | INSPIRE MED SYS INC | $9,042,000 | -29.3% | 150,000 | -12.9% | 0.42% | -17.6% |
| ALLK | Sell | ALLAKOS INC | $8,898,000 | -68.9% | 200,000 | -33.3% | 0.41% | -63.8% |
| KURA | Sell | KURA ONCOLOGY INC | $7,960,000 | -42.1% | 800,000 | -20.0% | 0.37% | -32.6% |
| HARP | Sell | HARPOON THERAPEUTICS INC | $7,527,000 | -21.7% | 649,993 | -0.0% | 0.35% | -8.9% |
| MRUS | Sell | MERUS N V | $7,260,000 | -48.4% | 600,000 | -40.0% | 0.34% | -40.0% |
| INSM | New | INSMED INC | $5,807,000 | – | 362,273 | +100.0% | 0.27% | – |
| EIGR | Sell | EIGER BIOPHARMACEUTICALS INC | $5,543,000 | -55.4% | 815,127 | -2.2% | 0.26% | -48.0% |
| BCEL | Sell | ATRECA INC | $5,398,000 | +7.0% | 326,139 | -0.0% | 0.25% | +24.9% |
| AVRO | AVROBIO INC | $4,942,000 | -22.7% | 317,579 | 0.0% | 0.23% | -9.8% | |
| ARNA | Sell | ARENA PHARMACEUTICALS INC | $4,200,000 | -46.3% | 100,000 | -42.0% | 0.20% | -37.5% |
| NERV | MINERVA NEUROSCIENCES INC | $3,660,000 | -15.3% | 607,903 | 0.0% | 0.17% | -1.2% | |
| AMRN | Sell | AMARIN CORP PLCspons adr new | $3,600,000 | -87.1% | 900,000 | -30.8% | 0.17% | -85.0% |
| ARCT | New | ARCTURUS THERAPEUTICS HLDG I | $3,561,000 | – | 262,037 | +100.0% | 0.16% | – |
| XFOR | Buy | X4 PHARMACEUTICALS INC | $3,416,000 | +26.3% | 341,618 | +35.2% | 0.16% | +47.2% |
| AUTL | AUTOLUS THERAPEUTICS PLCspon ads | $2,875,000 | -54.6% | 479,988 | 0.0% | 0.13% | -47.0% | |
| NKTR | Sell | NEKTAR THERAPEUTICS | $2,678,000 | -38.0% | 150,000 | -25.0% | 0.12% | -27.9% |
| TBPH | Buy | THERAVANCE BIOPHARMA INC | $2,311,000 | +78.5% | 100,000 | +100.0% | 0.11% | +105.8% |
| NBIX | Sell | NEUROCRINE BIOSCIENCES INC | $2,164,000 | -48.8% | 25,000 | -36.4% | 0.10% | -40.2% |
| DTIL | Sell | PRECISION BIOSCIENCES INC | $2,090,000 | -67.8% | 346,524 | -25.9% | 0.10% | -62.5% |
| GOSS | Sell | GOSSAMER BIO INC | $2,014,000 | -57.0% | 198,382 | -33.9% | 0.09% | -49.7% |
| ORTX | Sell | ORCHARD THERAPEUTICS PLCads | $1,933,000 | -59.9% | 256,649 | -26.7% | 0.09% | -53.1% |
| FATE | New | FATE THERAPEUTICS INC | $1,666,000 | – | 75,000 | +100.0% | 0.08% | – |
| OTLKW | OUTLOOK THERAPEUTICS INC*w exp 02/18/202 | $65,000 | +140.7% | 416,666 | 0.0% | 0.00% | +200.0% | |
| RARX | Exit | RA PHARMACEUTICALS INC | $0 | – | -295,600 | -100.0% | -0.55% | – |
| BHVN | Exit | BIOHAVEN PHARMACTL HLDG CO Lcall | $0 | – | -500,000 | -100.0% | -1.09% | – |
| XBI | Exit | SPDR SERIES TRUSTput | $0 | – | -500,000 | -100.0% | -1.90% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-05-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| QUOTIENT LTD | 30 | Q3 2021 | 4.3% |
| ASCENDIS PHARMA A/S | 30 | Q4 2022 | 4.8% |
| MINERVA NEUROSCIENCES INC | 29 | Q3 2021 | 4.4% |
| ACCELERON PHARMA INC | 28 | Q2 2021 | 3.4% |
| OMEROS CORP | 27 | Q3 2021 | 6.5% |
| MIRATI THERAPEUTICS INC | 25 | Q4 2022 | 7.6% |
| BLUEPRINT MEDICINES CORP | 25 | Q3 2021 | 3.6% |
| APELLIS PHARMACEUTICALS INC | 24 | Q3 2023 | 8.6% |
| NEUROCRINE BIOSCIENCES INC | 24 | Q1 2020 | 4.6% |
| ROCKET PHARMACEUTICALS, INC | 23 | Q3 2023 | 2.4% |
View Cormorant Asset Management, LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Ambrx Biopharma Inc. | March 13, 2023 | 42,771,365 | - |
| Altimmune, Inc. | February 14, 2023 | 2,600,000 | - |
| Arcellx, Inc. | February 14, 2023 | 2,075,000 | - |
| BioAtla, Inc. | February 14, 2023 | 2,499,250 | - |
| Eledon Pharmaceuticals, Inc. | February 14, 2023 | 1,391,663 | - |
| GreenLight Biosciences Holdings, PBC | February 14, 2023 | 4,751,020 | - |
| Prometheus Biosciences, Inc. | February 14, 2023 | 700,000 | - |
| Tango Therapeutics, Inc. | February 14, 2023 | 1,000,000 | - |
| VectivBio Holding AG | February 14, 2023 | 1,515,087 | - |
| Viridian Therapeutics, Inc.\DE | February 14, 2023 | 1,100,000 | - |
View Cormorant Asset Management, LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2024-04-22 |
| SC 13G/A | 2024-04-15 |
| 4 | 2024-04-03 |
| SC 13G | 2024-03-21 |
| 4 | 2024-03-18 |
| SC 13G/A | 2024-03-18 |
| 4 | 2024-03-11 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
View Cormorant Asset Management, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.